97G-16512-93451
1 vaccination
1 coded response
7 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 210 / MD
- Registered
- 2022-11-01
- Relationship
- Child or adolescent in my care
- Guardian
- BF4-62600-39492
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-22
Dose 1 — ModernaCo-administered: Flu
-
2022-11-01
Registered in v-safe
- 2022-11-01
- 2022-11-05
- 2022-11-12
- 2022-11-19
- 2022-11-26
-
2023-01-23
Survey response — 3 months, dose 1, under 3MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-01-23
Report sent to call center — 3 months, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2023-01-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-22 | Moderna | Flu |
Call center
1 call center case
1 successful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release